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Abstract
Background: Human endogenous retroviruses (HERVs) are flanked by long terminal repeats (LTRs), which possess
promoter activity and can therefore influence the expression of neighboring genes. HERV involvement in different
types of cancer has already been thoroughly documented. However, so far there has been no systematic study of
HERV expression patterns in a multitude of cell types in health and disease. In particular, the publication of the
comprehensive ENCODE dataset has already facilitated many gene expression studies, but none so far focusing
exclusively on HERVs.
Results: We present a comprehensive differential analysis of HERV expression based on ENCODE Tier 1 and Tier 2
RNA-seq data produced by Cold Spring Harbor Laboratories and the California Institute of Technology. This analysis
was conducted for individual HERV loci and for entire HERV families in twelve different cell lines, of which six
correspond to the normal condition and the other six represent cancer cell types. Although the principal component
analysis revealed that the two groups of cells show distinguishable expression patterns, we were not able to
link these differences to one or multiple particular HERV families. Two samples exhibit expression patterns,
which are not similar to the corresponding cell lines of the other producing lab. Instead they show signs of
cancer formation and expression of the pluripotency marker HERVH, despite being classified as a normal cell
line and a differentiated cell, respectively.
Conclusions: Our study demonstrates that ENCODE data are generally comparable between the different
contributing labs and that the analysis of HERV elements can provide novel insights into differentiation and
disease state of a cell that are easily overlooked when focusing on protein-coding genes. Our findings hint at a
change in HERV expression during cancerogenesis.
Keywords: Gene expression, Cancer, Next-generation sequencing
Background
Human endogenous retroviruses (HERVs) are remnants
of germline infections by exogenous retroviruses that
were integrated into the host genome and passed on to
the offspring. Estimates place the amount of human
DNA that has a retroviral origin at 8 % [1]. Due to the
presence of the proviral pol gene, which encodes the
reverse transcriptase, HERVs can reintegrate copies of
themselves in other genomic locations and hence belong
to the group of transposable elements. In addition to the
gag, pol and env genes, which are counterparts of the
original functional virus genes, HERVs also contain long
terminal repeat sequences (LTRs) at the 5’ and 3’ end.
These LTRs have a strong promoter function, which can
increase the transcription level of neighboring genes [2].
As internal viral genes tend to degrade over time due to
the absence of evolutionary pressure, many HERV se-
quences are lacking some, or even all of their ORFs, or
contain their fragments. In particular, many solitary LTR
sequences can be found in the human genome [3].
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Some of the HERV loci in the human genome have been
identified as being beneficial to the host. For example, syn-
cytin, encoded by the env gene of the HERV-W family is
linked to differentiation and morphogenesis of the placen-
tal tissue and hypothesized to have immunosuppressive
function that supports the maternofetal tolerance [4, 5].
There are also multiple studies linking HERVs to diseases
such as multiple sclerosis and schizophrenia [6, 7], al-
though they are mainly based on detecting elevated expres-
sion levels of certain HERV families in affected individuals
and do not necessarily shed light on causal relationships.
HERVs have also been implicated in breast cancer and
melanoma [8, 9] where samples of patients contained
expressed HERV genes, viral proteins and antibodies for
HERV peptides. However, in order to understand the
causative mechanisms of HERV involvement in disease, a
rigorous tissue specific differential expression analysis of
HERV families between disease and healthy states is critic-
ally required. Such differential analyses are complicated by
the fact that HERVs are repetitive elements spread over the
entire genome, which makes mapping of their transcripts
to genomic loci particularly challenging. Previous attempts
to create an overview of HERV expression patterns in dif-
ferent tissues relied on a specifically designed chip with
various captured retroviral pol sequences [10, 11] and were
thus limited to the subset of HERV family members that
still contain intact pol sequences. In order to increase the
number of covered retroviral elements, a more compre-
hensive approach, capable of identifying the full-length se-
quences would be required. RNA-Seq has become a
method of choice for addressing such problems [12] as it
provides precise measurements of transcript levels in the
cell and thus makes it possible to map all retroviral ele-
ments, both structurally intact and partial, back to their
genomic loci.
Over the past ten years the Encyclopedia Of DNA
Elements project (ENCODE) [13] has been working on
systematic identification of all functional elements in the
human genome. With the most recent data release, made
available in September 2014, ENCODE incorporates 27
different kinds of experiments, such as Exon Arrays,
ChiP-Seq, and RNA-Seq analyses, conducted by seven
research labs in order to gather as much information as
possible on a standardized group of cell lines. These cell
types are subdivided into three tiers depending on their
assigned priority. Tier 1, which only contains three differ-
ent cell types, constitutes the highest priority and has thus
the largest number of conducted studies associated with
it. All tiers include healthy cell lines as well as cancerous
ones, and all data submissions are also subdivided based
on the cellular compartments in which measurements
were performed. The ENCODE guidelines force submit-
ters to provide at least two biological replicates per experi-
ment for more robust statistical analyses. There are a total
of 151 RNA-Seq experiments in the ENCODE summary
of the first stage (2007–2012), with 87 of them using small
RNA-Seq (as of September 2014).
Since this valuable resource of highly standardized refer-
ence data became available, many research groups pub-
lished studies integrating or comparing the ENCODE data
to their own samples or conducting meta-analyses across
ENCODE cell lines [14–16]. ENCODE data has also been
used in computational studies on gene expression, but as
of now transcriptome analyses spanning multiple cell
types aim at protein-coding genes or functional regulatory
RNAs [17, 18]. Examination of ENCODE RNA-Seq data
with regard to HERV expression has either been limited
to single cell types or covers HERVs only as a very small
subset of the overall analysis [19, 20].
In this work we have comprehensively analyzed EN-
CODE RNA-Seq data covering all annotated HERV loci
in a broad variety of cell lines, disease and developmen-
tal stages. We sought to gain an insight into the overall
expression patterns of HERV elements and to examine
on a large scale if there are measurable differences in
HERV activity between cancer and normal cells, as already
reported for individual tumor types. Furthermore, a major
goal of our study was to assess the consistency of different
ENCODE-contributing laboratories with regard to expres-
sion values from the same cell lines.
We present the analysis of 25 RNA-Seq samples from
ENCODE’s top two priority tiers with regard to the ex-
pression of all annotated HERV loci obtained from the
HERVd database [21, 22]. We found that there are con-
siderable differences between the expression profiles
obtained by single- vs paired-end sequencing, with the
former showing lower overall expression. This finding
holds true both for HERVs and for housekeeping genes.
Apart from the discrepancies stemming from different
library designs and two cases probably caused by trans-
formation of the underlying cell lines, we did not observe
any striking distinctions between the data provided by the
two contributing laboratories. This suggests that EN-
CODEs quality standards are sufficient to provide a robust
basis for comparative analysis.
Upon removal of systematic errors resulting from dif-
ferent sequencing strategies, we were able to identify
unusual patterns in HERV expression in two of the ana-
lyzed cell lines. Members of the HERV-H family, con-
sidered to be a marker for pluripotency and normally
seen in embryonic stem cells (ESCs), are strongly over-
expressed in the HeLa-S3 cells. Furthermore, one blood
cell line, GM12878, shows a HERV expression profile,
which is more similar to cancerous blood cells than to
another healthy sample, potentially pointing to a can-
cerous transformation of this cell line. These findings
imply that patterns of HERV expression could serve as
useful markers in early cancer diagnostics.
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Results
Differential expression analysis shows strong differences
between sequencing technologies
We detected HERV expression in all analyzed samples.
The CSHL dataset has on average 120,411,532 mapped
fragments, of which 0.73 % are assigned to HERV loci.
In Caltech’s paired-end data set, featureCount works
with 67,730,782 fragments on average, of which approxi-
mately 1.3 % have been mapped to HERVd annotations.
The single-end data sets include on average 20,640,141
reads, with 0.42 % of them assigned to HERV loci. A list
showing all numbers of mapped fragments per sample
as well as the fraction being assigned to HERV loci can
be found in Additional file 1.
The principal component analysis of the transformed
expression values of all 25 samples (Fig. 1) shows that
the strongest differences in HERV expression result from
variations of the sequencing technology used. The first
principal component (which captures 19.06 % of the
total variance) clearly subdivides the Caltech samples
into those analyzed by single- and paired-end sequen-
cing. The second and third principal components, ac-
counting for 10.30 % and 5.70 % of the variance,
respectively, separate certain cell types from the rest of
the datasets. While the second component clusters to-
gether all eight embryonic stem cell samples, the third
component lets the six K562 samples stand out. Finally,
the fourth component (5.01 % of the variance) mostly
reflects the differences between normal and cancer cell
types, with the exception of the MCF-7 sample from
Caltech where one replicate is clearly separated from the
other two and overlaps with a normal tissue (HUVEC).
Given that single-end datasets lead to very different



















































Fig. 1 Principal component analysis of normalized HERV expression values in 25 ENCODE RNA-Seq data sets. The first, second, third, and fourth
principal components account for 19.06 %, 10.30 %; 5.70 %, and 5.01 % of the variance, respectively. Each data point represents one replicate.
Circles: normal cell lines; squares: cancer cells; filled symbols: CSHL samples; empty symbols: Caltech; crosses in the symbols: single-end sequencing.
a The first component separates single- and paired-end libraries, while the second separates ESC samples from all the others. b The third component
separates K562 from the other cell types. c The fourth component divides samples into normal and cancerous cell types
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decided to exclude them from the further analyses to pre-
vent them from introducing a bias into the expression
data. The paired-end data seems to give a better overview
of the expression rates. Note that in the GEO summary of
the ENCODE Caltech RNA-Seq data, the single-end
protocol which is also strand-specific, is described as less
reliable for quantification [http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE33480].
Housekeeping genes confirm strong differences in
ENCODE expression data, especially between different
sequencing protocols
Differences in expression of housekeeping genes were
also mostly due to the used library protocols. While the
first principal component (accounting for 30.67 % of the
variance) primarily divides the CSHL cell lines into can-
cerous and normal ones (with the exception of CSHL’s
GM12878 and a small overlap involving SK-N-SH), the
samples provided by Caltech are neatly separated into
paired- and single-end protocols (Fig. 2). A hierarchical
clustering of housekeeping genes based on the Euclidean
distances between their expression vectors yields three
subtrees. One of them contains exclusively Caltech and
the other two contain only CSHL samples. The two
CSHL subtrees separate nearly perfectly cancerous from
normal call lines, with the exception of GM12878 and
SK-N-SH (Fig. 3).
The observed differences thus do not depend on the
chosen transcript family, but are rather indeed an inher-
ent pattern in the ENCODE datasets.
Two cell lines show behavior atypical for their disease
and developmental stage
After excluding the single-end Caltech samples, we cal-
culated the Euclidean distances between the transformed
expression vectors for all remaining paired-end datasets
and performed a hierarchical clustering. As seen in
Fig. 4, most replicates are highly similar to each other
with regard to HERV expression, with the exception of
IMR90 and the second replicate of Caltech’s MCF7 se-
quencing. ESCs are clearly the most diverse among the
differentiated cell types, serving as an outgroup. Par-
ticularly striking is the clustering of CSHL’s GM12878
replicates. While the same cell line, analyzed by
Caltech, is branched together with two other healthy
blood cell types, GM12878’s expression vectors deter-
mined at CSHL cluster with all four examined blood
cancer samples (K562).
In addition to the global clustering presented above
we also compared every condition against every other
condition in a pairwise fashion, leading to 171 differ-
ential expression analyses. Following the common
practice [23, 24] we defined significantly differentially
expressed HERV loci as those with an absolute value
of the logarithmic fold change of at least one and the
adjusted p-value smaller than 0.001 (FDR of 0.1 %).
The number of identified loci varied depending on
the compared samples (Fig. 5). Pairwise analyses in-
volving embryonic stem cells led to the largest num-
ber of differences with up to 956 significant loci
(Caltech H1-hESC vs. CSHL HepG2). The smallest
number of significantly differentially expressed loci
between two different cell types is three and occurs
three times (Caltech and CSHL HUVEC vs. IMR90
and Caltech MCF-7 vs. CSHL HeLa-S3). While the
largest numbers of differentially expressed HERVs are
seen when ESCs are compared to the other cell types,
it is remarkable that Caltech’s HeLa-S3 line shows
very few loci, which are significant in comparison



























Fig. 2 Principal component analysis of normalized expression values of housekeeping genes in 25 ENCODE RNA-Seq data sets. The first and the
second principal components account for 30.67 % and 21.33 % of variance, respectively. Circles: normal cell lines; Squares; cancer data sets; Filled
symbols: CSHL; Empty symbols: Caltech; crosses in the symbols: single-end sequencing
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Caltech’s HeLa-S3 cell line shows a strong up-regulation
of HERVH, typical for embryonic stem cells
Upon extracting all significantly over-expressed loci per
cell type from the pairwise comparisons and grouping
them by their family affiliation, we observed characteris-
tic patterns for different samples. The eight most often
up-regulated HERV families are four internal and four
LTR sequences (Fig. 6). Internal regions that are most
overexpressed in the pairwise comparisons are ERVL, a
very old endogenous element that is found even outside
of primates and shows high similarity to foamy retrovi-
ruses [25] and its younger relative HERVL. Additionally,
two LTR sequences, LTR16C and LTR33, are also among
the eight most often overexpressed families, which be-
long to the ERVL superfamily. The other two internal
families are the pluripotency marker HERVH and the
young human endogenous viral element, which is also
the most active in terms of expression and transposition,
HERVK [26]. The two additional often up-regulated LTR
sequences are LTR7, which is a long terminal repeat se-
quence of HERVH, and LTR12, belonging to the HERV
superfamily ERV1.
Overall, the same cell types analyzed by any two la-
boratories show a similar composition of HERV families,
with the exception of GM12878 from CSHL, which ex-
hibits a nearly double amount of significant HERVs
compared to its Caltech counterpart. Especially the large
number of ERVL members in the CSHL sample is un-
matched in the corresponding Caltech cell line. The only
other cell types with a similar large number of active
HERVL loci is CSHL’s K562 sample, which is also a
blood cell type, but contrary to GM12878 cancerous.
Another cell line that exhibits an extremely deviant
behavior in the lab comparison is HeLa-S3 from Caltech.
It appears to over-express an immense amount of HERVH
family members (290 loci), which are only found in
low numbers in all other specialized cells. The over-
expression is not as strong as in the embryonic stem
cells, but is higher than any other number of a single
HERV family in all other cell lines (Fig. 6). The differ-
ence between cancerous and normal cell lines revealed
by the principal component analysis could not be
linked to a particular overexpressed HERV family. We
were not able to identify any expression patterns sep-
arating the six normal from the six cancer cell lines on
the basis of individual HERV families.
Discussion
Based on the comprehensive analysis of 25 RNA-Seq sam-
ples from the ENCODE project with regard to their HERV
expression we find that datasets created with different se-




















































































Fig. 3 Hierarchical clustering of Euclidean distances between the transformed expression values of housekeeping genes. “RepN” in the dataset
identifier represents the replicate number n. Normal and cancer cell lines are shown by circles and squares, respectively. Samples analyzed by
CSHL are drawn with filled symbols, those from Caltech are drawn with blank symbols
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very easily comparable, because single-end samples achieve
less coverage. This is expected, as the sequencing tech-
nique used by Caltech is strand specific and as such trades
quantification against a qualitative analysis.
Although a principal component analysis of the HERV
expression patterns in different cell types revealed the
possibility to distinguish cancerous from healthy samples
based on HERV activity, we could not link this difference
to a specific HERV family. However, our study revealed
unexpected results regarding GM12878 from CSHL,
which showed hints of being a tumorous cell line in two
different analyses. First, a hierarchical clustering of all
HERV loci expression grouped this cell type with all four
K562 (blood cancer) replicates instead of the GM12878
samples from CSHL. Second, the composition of up-
regulated HERV families in this sample, when compared
to all others, is much more similar to that of K562, espe-
cially regarding the strong activity of ERVL. A possible
reason for this behavior could be the transformation of
an initially normal cell line to a tumorous one prior to
experimental measurements. However, this explanation
does not seem to be particularly plausible given that
ENCODE imposes strict data quality requirements, espe-
cially with regard to tier 1 cell lines to which GM12878
belongs. The respective Caltech GM12878 RNA-Seq
track has been accessible through the UCSC genome
browser [27, 28] since August 2012 and so far no unusual
features of this dataset, including a possible progression
towards a tumor line, have been reported. It is conceiv-
able that the change in HERV expression detected in
our study, which is the first comprehensive investiga-
tion of HERV expression in ENCODE samples, occurs
very early in the transition from a normal to a cancer
cell type and hence remained undetected in studies fo-
cusing on protein-coding gene expression, although we
were able to detect aberrant behavior hinting at this
change when performing PCA on housekeeping genes.
Further research is needed to verify this hypothesis, as
it implies that unusual HERV expression could serve as
an early indication of carcinogenic transformation and
thus represent a valuable diagnostic lead.
Another striking finding is the low amount of differen-
tially expressed HERVs when comparing Caltech’s HeLa-S3
sample to the ESCs. The strongest difference between
HERV expression in ESCs compared against specialized
cell types is the very strong up-regulation of HERVH family
members. Because HERVH activity is also high in Caltech’s
HeLa cells, unmatched in any of the other differentiated
cell types, the difference in expression pattern to ESCs is
understandably small. The HERVH family is known to play
a vital role in embryonic stem cells. In particular, since they



































































Fig. 4 Hierarchical clustering of Euclidean distances between the transformed expression values in paired-end ENCODE data sets. “Rn” in the
dataset identifier represents the replicate number n. Circles show normal, squares cancer cell lines. Samples analyzed by CSHL are drawn with
filled symbols, those from Caltech are drawn with blank symbols
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association with binding sites for the pluripotency tran-
scription factors NANOG, OCT4 and SOX2 [29]. Fur-
thermore, it has been suggested that HERVH and its
LTR7 can recruit the transcription factors p300 and
OCT4 to regulate the transcription of pluripotency-
associated transcripts [20]. Intriguingly, Santoni et al.
also used ENCODE RNA-Seq data from Caltech to
analyze HERVs in hESCs, although they relied on the
2010 data release whereas in this study we utilized the
most recent data published in 2012. For comparison
with differentiated cells, Santoni et al. also obtained the
2010 data on corresponding HeLa-S3 cells and found
that “HERV-H expression is barely detectable in HeLa”,
although it was identified when using transient-
transfection assays [30]. It is thus apparent that there




























































































































































































































Fig. 5 Heatmap of significantly differentially expressed HERV loci. Number of significantly (|log2 fold change| at least one, adjusted p-value < 0.001)
differentially expressed HERV loci in pairwise comparisons. Ice blue fields show comparisons yielding none or very few differentially expressed loci, hot
pink represents large numbers (up to 956)
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2012 HERV expression data submitted to the ENCODE
project by Caltech.
Santoni et al. observed that the HERV expression
strength in ESCs diminishes during differentiation. Ex-
pression is highest at the undifferentiated N0 stage, still
observable during N1 (early initiation), and only barely
measurable during N2 (neural progenitor). Thus, a con-
ceivable explanation for the behavior of Caltech’s HeLa-S3
cells would be reprogramming towards pluripotency,
although an underlying mechanism for this process re-
mains enigmatic.
Conclusions
In this study we analyzed the expression of known human
endogenous retroviral elements in RNA-Seq samples from
the ENCODE project. It is the first examination of se-
quencing data from a variety of cell types and labs with
regard to HERV expression patterns.
We found that all analyzed cell lines have active
HERV loci and, by performing differential expression
analysis, we identified cell type specific expression pat-
terns. Our analysis also revealed discrepancies between
different RNA-Seq datasets: single cell lines showed sig-
nificantly different expression profiles depending on the
laboratory where measurements were conducted. We
verified that this finding was not due to the particular
kind of transcripts considered, namely HERVs, by re-
peating the same analysis with housekeeping genes.
Furthermore, in two cases deviant expression patterns
were closer to those of a completely different cell type
than the same line from a different research institution.
Thus, we believe it is of particular importance to
monitor cultured cell lines very closely as small changes
to a cell type can lead to major alterations of expression
patterns for some non-coding RNAs. While conducting
differential expression analysis it might not be sufficient
to regard even identical cell lines as comparable. Our
analysis of cancer-specific HERV families is further com-
plicated by consideration of distinctly different cancer
cell lines. However, PCA shows that there is an inform-
ative signal in the expression data differentiating cancer
from normal cell lines.
If further investigations confirm that a change in
HERV expression patterns is an early sign of cell trans-




We obtained RNA-Seq data for the ENCODE Tier 1 and
Tier 2 cell types mapped against the latest human genome
assembly (hg19) using the UCSC track download portal

































































































































































































Fig. 6 Up-regulated HERV families in different cell types. The plot shows HERV families that are significantly stronger expressed when comparing
the indicated cell type against all others. All families that have fewer than 20 members significantly overexpressed in all samples are grouped
together in the “other” class
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RNA extracts (>200 bp) were considered, as short RNA
extractions aim at identifying small non-coding RNAs
while our proviral remnants of interest are considerably
longer (mean length of 928 nt). We further restricted the
considered tracks to whole cell extracts, as we are inter-
ested in the overall analysis of HERV expression in the en-
tire human cells rather than in individual compartments.
We focused on data produced by either the Cold Spring
Harbor Laboratories (CSHL) or the California Institute of
Technology (Caltech) (Table 1) because these provide
the most comprehensive coverage of (mostly) the same
cell types, facilitating a direct comparison of the results
produced by these two groups. Moreover, due to the fact
that Caltech performed both single-end and paired-
end sequencing on a subset of cell types, expression
analysis results can also be compared between differ-
ent library preparations. However, the single-end data
sets contain fewer reads and we therefore investigated
whether or not this lower coverage is still sufficient
to detect HERVs, which make up only a small frac-
tion of the cell’s transcriptome.
HERV annotation
We used the currently most comprehensive collection of
annotated HERVs, the HERVd database [21, 22]. This
database contains 98,008 entries describing 224 different
HERV families, from full-length proviral elements to sin-
gular Long Terminal Repeats (LTRs). Since the HERVd
annotation is based on the hg17 assembly of the human
genome we transferred all genomic coordinates to hg19
using the liftOver tool [27].
A number of HERVd entries did not survive the lifting
process: 2,342 entries are completely or partially deleted
and another 24 entries are split in the latest hg19 assem-
bly. We nevertheless attempted to identify the location
of these entries in hg19 by sequence similarity searches
using BLAT [33]. Similarity hits were accepted as the
origin of a given HERV if the corresponding alignments
were gap free, covered the complete query sequence,
and had a minimum sequence identity of at least 98 %.
In the same fashion we identified additional viral elements
in hg19 by using all known HERV sequences as query and
accepting new origins when they met the identity cutoff. It
should be noted that we only performed similarity searches
in regions without existing HERV annotations to avoid du-
plicated entries. However, while the initial HERVd already
contains HERV loci that are overlapping with each other,
we decided against filtering these out in order not to lose
HERV annotations.
Our initial HERV data set contained 100,495 loca-
tions in hg19. HERVd entries located on chromosome
Y were excluded from consideration as this chromo-
some is not covered by all ENCODE datasets used in
our study. This filtering step left us with a total of
98,998 annotated HERV loci (Additional file 2) for
which we obtained read counts.
HERV expression in ENCODE RNA-Seq
We calculated the read coverage over the HERVd entries
for every RNA-Seq experiment using the “featureCount”
tool of the subread package [34]. For every annotated
viral element it returns the number of reads mapped to
it in every analyzed sequencing run. The program was
executed with the “primary” option, which forces fea-
tureCount to only take primary alignments into account,
thus avoiding biased expression values through non-
uniquely mapped reads. This is extremely important
when working on HERV loci, as the different families,
due to their varying integration ages, have unequal de-
grees of similarities among the family members. Thus, it
Table 1 ENCODE RNA-Seq data used in this study
Cell type Tissue Condition Number of replicates
Tier CSHL paired-end Caltech single-end Caltech paired-end
A549 Epithelium Cancer 2 2 - -
B-cells CD20+ Blood Normal 2 2 - -
GM12878 Blood Normal 1 2 2 2
H1-hESC ESC Normal 1 2 2 4
HUVEC Blood vessel Normal 2 2 2 2
HeLa-S3 Cervix Cancer 2 2 2 2
HepG2 Liver Cancer 2 2 2 2
IMR90 Lung Normal 2 2 - -
K562 Blood Cancer 1 2 2 2
MCF-7 Breast Cancer 2 2 - 3
Monocytes CD14+ Monocytes Normal 2 2 - -
SK-N-SH Brain Cancer 2 2 - -
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is easier to assign a read to its exact loci for older and
more distinct families than for younger families. An alter-
native to using the primary alignment would be to only
use uniquely mapped reads, but this would bias the ex-
pression values towards older HERV families (see Fig. 7).
Furthermore, in the data sets comprised of paired-end
reads the entire fragment was counted only once to
maintain comparability with the single-end samples.
Reads in stranded datasets were counted in a strand-
specific manner; these include the single-ended Caltech
samples and all CSHL samples.
Differential expression analysis
The coverage depth of HERV loci between 25 ENCODE
samples (Table 1) was compared using the R bioconduc-
tor package DESeq [35–37] , which is specially designed
for differential expression analysis. To achieve a better
comparability between samples we normalized their
count data by library size and carried out a variance sta-
bilizing transformation based on the inherent biological
variability between the replicates of the same condition.
We then performed a principal component analysis
(PCA) and calculated the Euclidean distances between
the transformed expression values to detect overall dif-
ferences between the samples.
The following analyses were limited to the paired-end
RNA-Seq data as PCA revealed extensive differences be-
tween single- and paired-end library preparations. Hence
to avoid introducing a bias in the differential expression
analysis, we excluded single-end data. The read count
value of every condition, normalized by the library size,
was compared in a pairwise fashion against every other
condition, resulting in 171 differential expression ana-
lyses and the corresponding fold changes. The DESeq
implementation of the negative binomial test was than
used to find significant differences in the calculated ex-
pression values. The initial p-values were adjusted for
multiple testing using the Benjamini-Hochberg proced-
ure [38] . In order to identify significantly differentially
expressed HERVs we filtered for loci whose absolute
logarithmic fold change was at least one and whose ad-
justed p-Value did not exceed 0.001 (which is equivalent
to a false discovery rate of 0.1 %).
For every analyzed cell type, we compiled a list of
HERV loci up-regulated in at least one of the pairwise
comparisons. By considering the corresponding families
of loci, we sought to identify HERVs that are particularly
active in certain cell types and under certain conditions.
Validation on housekeeping genes
In order to ascertain that the differences in HERV expres-
sion between different conditions and library preparations
reported in this study are not due to computational or ex-
perimental biases specific to endogenous viral elements,
we repeated our analysis with a set of housekeeping genes.
For this purpose we used the list of 3,804 genes compiled
by Eisenberg and Levanon [39]. This list was created based
on RNA-seq data from 16 different human tissues by first
Fig. 7 Fraction of uniquely mapped reads. The left box shows the fraction of reads uniquely mapped to HERV loci across all ENCODE samples.
The middle box contains the same values for members of the recently integrated HERVK family. The right box shows the family members of
ERVL, a very old HERV family
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identifying housekeeping exons, i.e. those exons expressed
in all tissues, displaying low variance between tissues, and
showing no exceptional expression in any single data set.
Housekeeping genes were then defined as those genes, for
which at least one annotated RefSeq transcript has more
than half of its exons classified as housekeeping. When ac-
quiring the annotation file for the housekeeping genes
from the UCSC genome browser, only 3,801 entries could
be retrieved, as three identifiers [RefSeq: NM_032937,
NM_003926, NM_032560] had been removed from the
RefSeq database. The assessment of coverage for every
housekeeping gene in all our selected ENCODE data sets
was carried out exactly as described above for HERVd, in-
cluding normalization and principal component ana-
lysis (The featureCount output for all housekeeping genes
can be found in Additional file 3).
Additional files
Additional file 1: Read statistics per sample. For all analyzed ENCODE
samples the number of fragments/reads which are used as input for
featureCount are listed as well as the fraction of reads mapping to HERVd
annotated loci. (CSV 1 kb)
Additional file 2: HERVd annotation of HERV loci in hg19. Tabular
file contains columns for unique identifier, chromosome, start and stop
position, strand and HERV family, respectively. The remaining columns
represent the read counts from featureCount for all of the analyzed
ENCODE samples. (CSV 14292 kb)
Additional file 3: Read counts of housekeeping genes. Tabular file
containing the featureCount counts for all genes classified as
housekeeping by Eisenberg and Levanon [39]. (CSV 1000 kb)
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